Skip to content

Research on Serum Copeptin as Biomarkersfor Diagnosis and Classification of Polyric Primary monosymptomatic nocturnal enuresis

Research on Serum Copeptin as Biomarkersfor Diagnosis and Classification of Polyric Primary monosymptomatic nocturnal enuresis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121684
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary monosymptomatic nocturnal enuresis

Interventions

Gold Standard:Diagnostic criteria for primary monosymptomatic nocturnal enuresis: Age = 5 years, at least 1 episode of involuntary nocturnal urination per month for more than 3 months, without concurr
Index test:Serum copeptin detection: ELISA . Commercially available human copeptin ELISA kits were used
Urine AQP-2 detection: ELISA method. The corresponding human AQP-2 ELISA kit.Other tests: Urine specific gravity, osmotic pressure, fasting blood glucose, blood routine, urine creatinine, blood creati

Sponsors

Children's Hospital,Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Case Group: 1. Age 5-18 years. 2. No treatment within 1 month prior to the trial. 3. Able to complete a 2-day, 7-night urination diary and study-related questionnaires. 4. Guardians and the children themselves agree to participate in the study and sign informed consent forms. 5. Meet the 2025 nocturnal enuresis guideline diagnostic criteria for PMNE: age >=5 years, at least 1 episode of involuntary urination at night per month, lasting more than 3 months, without daytime lower urinary tract symptoms or organic urinary system diseases. Healthy Control Group: 1. Children with no history of nocturnal enuresis or abnormal daytime urination, and no history of chronic kidney, endocrine, or nervous system diseases, including: normal urine routine, serum creatinine value, eGFR value, and urinary system B-ultrasound. 2. No recent acute infections, dehydration, or excessive water intake. 3. No treatment within 1 month prior to the trial.

Exclusion criteria

Exclusion criteria: 1. Patients under the age of 5; 2. Patients with daytime lower urinary tract symptoms or history of bladder dysfunction; 3. Patients with secondary nocturnal enuresis who have experienced at least 6 months of dry bed period; 4. Patients with chronic diseases.

Design outcomes

Primary

MeasureTime frame
Serum copeptin; ;Urine AQP-2 test;;

Countries

China

Contacts

Public ContactMao Jianhua

Children's Hospital,Zhejiang University School of Medicine

maojh88@gmail.com+86 571 88870015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026